Discontinued — last reported Q4 '23
Other Income (Expense)
Merck & Co. Other Income (Expense) remained flat by 0.0% to -$116.50M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 69.0%, from -$375.25M to -$116.50M. Over 2 years (FY 2021 to FY 2023), Other Income (Expense) shows a downward trend with a -41.1% CAGR.
Analysis
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_netHistorical Data
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $1.34B | -$1.50B | -$466.00M |
| YoY Change | — | -211.9% | +69.0% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical | -$14.00M | -$27.00M | $163.00M | -$49.00M | -$21.00M | -$60.00M | $295.00M | -$55.00M |
| Animal Health | $1.00M | $1.00M | -$2.00M | -$1.00M | $0.00 | -$1.00M | — | $0.00 |
| Total | — | — | — | — | — | — | — | — |
Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s other income (expense)?
- Merck & Co. (MRK) reported other income (expense) of -$116.50M in Q4 2023.
- How has Merck & Co.'s other income (expense) changed year-over-year?
- Merck & Co.'s other income (expense) increased by 69.0% year-over-year, from -$375.25M to -$116.50M.
- What is the long-term trend for Merck & Co.'s other income (expense)?
- Over 2 years (2021 to 2023), Merck & Co.'s other income (expense) has grown at a -41.1% compound annual growth rate (CAGR), from $1.34B to -$466.00M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.